Figure 6.
Transendothelial migration across bone marrow endothelium after 24 and 48 hours of incubation with imatinib. The mean absolute cell number (± SE) of migrated hematopoietic progenitor cells treated with imatinib (1.25 μM) for 24 or 48 hours is shown.